영업이익률 악화 (-27.9% → -71.6%, -43.7%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
USD/PYG
A042040 · KOSDAQUSD/PYG — pricey right now, or cheap? And what signals are flashing today?
The grade and valuation bands are below — free to read.
Why these signals fired — only backtest-proven edge, told honestly
New high + volume — the real recordrecord · not a prediction
Not this one stock, but every new-high-plus-volume pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-25)
Beat the market on 45.3% of picks (each pick vs its own day’s market average).
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Trade plan
Decide the exit before you enter. Set what you are willing to lose first, and the share count follows — so you know the worst case before you buy.
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
This is a calculator, not advice, and it does not promise any outcome. You choose the stop and target — the button values (ATR, recent low/high) are observations from past prices. Actual fills depend on the order book and liquidity.
Valuation Grades
Relative to 108 화학 peers · not investment advice
Valuation in its own history
PER — · PBR 0.14 — own history (2003-01~) percentiles 0/100 · 100/100
Higher indicates lower valuation relative to its history (based on earnings and book yields).
Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.
Financial safety
Reference indicatorAs of 2024- Altman Z''
- -3.64
- Beneish M-Score
- -4.03
- Sloan accrual
- -22.52%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
Piotroski measures year-over-year financial improvement, not absolute quality.
Profitability
- Positive ROANot passed
- Positive OCFNot passed
- Improving ΔROANot passed
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioNot passed
- No new sharesNot passed
Efficiency
- Higher gross marginPass
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
영업외손익 급변 (영업이익 대비 178% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Industry structure
KRAs of 2026-08-25화학
This stock is in 화학: revenue rank 101 of 107, share 0%.
Who dominates this industry?
- 1LG화학31.9%
- 2롯데케미칼13.3%
- 3금호석유화학4.7%
- 4DL3.7%
- 5코오롱인더3.2%
- 6케이피엠테크0%
Concentration
DistributedCR3 49.9%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
MixedConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 8.7
- Direction
- 확대
- Level
- 보통
- Years
- 6
Value lens
- P90/P10
- 9.6
- Median P/B
- 0.68
- Level
- 넓음
- n
- 95
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- -71.6%
- Interest coverage
- -5.9x
- Return on equity (ROE)
- -51.5%
Operating margin −5pp
Operating lossRevenue −15%
Interest coverage riskInterest rate +2pp
Interest coverage riskInterest coverage limit
Already below the limit by 83.7ppInterest coverage limit at an operating margin of 12.1%
Interest expense coverage threshold
Key suppliers · Annual report
Annual reportDART · 2026-03-23Suppliers disclosed by the company in its 2026-03-23 annual report.
Purchase amount
KRW 100m- 한국금거래소쓰리엠KRW 475.7B
- 성원컴퍼니KRW 249B
- 중앙피앤에이외KRW 188.4B
- PDSOLKRW 100.7B
- 씨엔비케미칼KRW 100.7B
Suppliers without disclosed amount
Financials at a glance
USD/PYG's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
5%+ major-holding disclosures
- 텔콘RF제약80.81%2026-07-16 · 증감 +48.13%p
- 상상인저축은행21.46%2025-12-23 · 증감 +4.38%p
- 에이비온10.07%2024-12-30 · 증감 +10.07%p
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- KR모터스KRA000040 →
Shared holders: 상상인저축은행
- 대양금속KRA009190 →
Shared holders: 상상인저축은행
- 삼보산업KRA009620 →
Shared holders: 상상인저축은행
- 우성머티리얼스KRA011300 →
Shared holders: 상상인저축은행
- 차AI헬스케어KRA025620 →
Shared holders: 상상인저축은행
- 소프트센KRA032680 →
Shared holders: 상상인저축은행
- 해성에어로보틱스KRA059270 →
Shared holders: 상상인저축은행
- 에이전트AIKRA060900 →
Shared holders: 상상인저축은행
Recent filings
USD/PYG's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy